Nimodipine Pharmacokinetic Variability in Various Patient Populations

Nimodipine has been shown to improve outcomes following aneurysmal subarachnoid hemorrhage. Guidelines recommend that all patients receive a fixed dose of oral nimodipine for 21 days. However, pharmacokinetic studies have suggested variability of nimodipine pharmacokinetics in subarachnoid hemorrhag...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Sherif Hanafy, Ji, Xinqi, Isse, Fadumo Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691411/
https://www.ncbi.nlm.nih.gov/pubmed/32902829
http://dx.doi.org/10.1007/s40268-020-00322-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691411/
https://www.ncbi.nlm.nih.gov/pubmed/32902829
http://dx.doi.org/10.1007/s40268-020-00322-3

Ejemplares similares